STANFORD BIODESIGN POLICY PROGRAM
HEALTH TECHNOLOGY INNOVATION POLICY CONFERENCE 2024
Ken Drazan, MD
CHAIRMAN, CEO & CO-FOUNDER, ARSENALBIO
Ken Drazan, MD is Chairman, CEO, and co-founder of ArsenalBio. Immediately prior to Arsenal, Ken held the positions of President and Chief Business Officer of GRAIL (Acquired by ILMN). Prior to GRAIL, Ken founded and was a Board Director of Verb Surgical (Acquired by JNJ). Ken also co-founded private equity firm Bertram Capital with .9B AUM. Ken is a Board certified liver transplant surgeon with previous faculty appointments at Stanford and UCLA